U-Neuron Biomedical (ROCO:6973) FCF Margin %: -53.03% (As of Dec. 2025)


ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$33.75
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical FCF Margin %?

U-Neuron Biomedical ROCO:6973 12 FCF Margin % is -53.03% as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, U-Neuron Biomedical ranks worse than 52.42% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. U-Neuron Biomedical's Free Cash Flow for the six months ended in Dec. 2025 was NT$-22.58 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2025 was NT$42.58 Mil. Therefore, U-Neuron Biomedical's FCF Margin % for the quarter that ended in Dec. 2025 was -53.03%.

As of today, U-Neuron Biomedical's current FCF Yield % is -6.58%.

The historical rank and industry rank for U-Neuron Biomedical's FCF Margin % or its related term are showing as below:

ROCO:6973' s FCF Margin % Range Over the Past 10 Years
Min: -213.77   Med: -148.38   Max: -8.84
Current: -103.53

During the past 6 years, the highest FCF Margin % of U-Neuron Biomedical was -8.84%. The lowest was -213.77%. And the median was -148.38%.

ROCO:6973's FCF Margin % is ranked worse than
52.42% of 950 companies
in the Biotechnology industry
Industry Median: -84.535 vs ROCO:6973: -103.53

U-Neuron Biomedical FCF Margin % Related Terms

U-Neuron Biomedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical FCF Margin % Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -8.84 -148.38 -205.75 -213.77 -103.53

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -134.55 -351.49 -101.04 -157.16 -53.03

ROCO:6973 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, U-Neuron Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's FCF Margin % falls into.


ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-85.579/82.663
=-103.53 %

U-Neuron Biomedical's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-22.581/42.579
=-53.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -53.03% mean?
U-Neuron Biomedical (ROCO:6973) has a FCF Margin % of -53.03% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on U-Neuron Biomedical and its competitors. According to the industry distribution chart, U-Neuron Biomedical ranks #498 out of 950 companies in the Biotechnology industry, placing it in the top 52.4%.
Is U-Neuron Biomedical's FCF Margin % too high?
U-Neuron Biomedical's current FCF Margin % is -53.03%. Based on the distribution chart, U-Neuron Biomedical ranks #498 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, U-Neuron Biomedical ranks #498 out of 950 companies for FCF Margin %. This places U-Neuron Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current FCF Margin % is -53.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current FCF Margin % of -53.03%. The current FCF Margin % is -53.03%. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current FCF Margin % is -53.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.75
Price